“1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients With Moderate Alzheimer Disease”. 2025. VITAE Academia Biomédica Digital 3 (24). https://sosvitae.ucv.ve/index.php/vitae/article/view/391.